Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The serotonin transporter from human brain: purification and partial characterization

A Rotondo1, G Giannaccini, L Betti

  • 1Institute of Psychiatry, University of Pisa, Italy.

Neurochemistry International
|March 1, 1996
PubMed
Summary

Researchers purified the serotonin (5-HT) transporter and found that binding sites for antidepressants and 5-HT overlap. This suggests a common interaction mechanism for these molecules on the transporter.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular Dynamics of a Polymer Blend Model on a Solid Substrate.

Molecules (Basel, Switzerland)·2025
Same author

A Novel Panel of Serum Biomarkers for MPM Diagnosis.

Disease markers·2017
Same author

Bottom-up proteomics suggests an association between differential expression of mitochondrial proteins and chronic fatigue syndrome.

Translational psychiatry·2016
Same author

Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.

Neurogastroenterology and motility·2016
Same author

The P2X7 receptor is a key modulator of the PI3K/GSK3β/VEGF signaling network: evidence in experimental neuroblastoma.

Oncogene·2015
Same author

Involvement of proteasome and macrophages M2 in the protection afforded by telmisartan against the acute myocardial infarction in Zucker diabetic fatty rats with metabolic syndrome.

Mediators of inflammation·2014

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pharmacology

Background:

  • The serotonin (5-HT) transporter is a key target for antidepressants.
  • Understanding the binding sites of different ligands is crucial for drug development.

Purpose of the Study:

  • To purify the human striatal 5-HT transporter.
  • To investigate the spatial relationship between binding sites for tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs).

Main Methods:

  • Solubilization and purification of the 5-HT transporter using digitonin and affinity chromatography.
  • Radioligand binding assays with [3H]-imipramine (TCA) and [3H]-paroxetine (SSRI).
  • Analysis of binding kinetics and molecular mass estimation via gel-exclusion chromatography and SDS-PAGE.

Related Experiment Videos

Main Results:

  • The purified 5-HT transporter complex has a molecular mass of 205 kDa and a single 67 kDa band in SDS-PAGE.
  • [3H]-paroxetine bound to a single high-affinity site on both membrane and purified transporter.
  • [3H]-imipramine exhibited different binding affinities on membranes versus purified transporter, suggesting conformational changes.
  • TCAs, SSRIs, and 5-HT displaced radioligands from high-affinity sites with similar binding capacities, indicating overlapping binding sites.

Conclusions:

  • The 5-HT transporter possesses overlapping binding sites for TCAs, SSRIs, and 5-HT.
  • These findings provide insights into the molecular interactions of antidepressants with their target.
  • The study highlights the utility of purified transporter systems for characterizing drug-target interactions.